[Changes of inflammatory factors after hepatic cystic echinococcosis surgery and intervention of ulinastatin in Qinghai area]

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019 Feb 26;30(6):667-670. doi: 10.16250/j.32.1374.2018089.
[Article in Chinese]

Abstract

Objective: To observe the changes of inflammatory factors after the hepatic cystic echinococcosis surgery and explore the intervention effect of ulinastatin on postoperative inflammatory factors.

Methods: Sixty patients with hepatic cystic echinococcosis were selected and randomly divided into a control group and ulinastatin intervention group according to whether or not use ulinastatin. The peripheral venous blood was extracted in all the patients and the levels of IL-6, IL-8, IL-9, and IL-10 were detected by the ELISA method on the day before operation, 1 day, 3 days, 5 days and 7 days after operation, respectively. The data was statistical analyzed to detect the relationships between/among the inflammatory factors mentioned above and ulina-statin and time.

Results: The variation of the levels of IL-6, IL-8, IL-9, and IL-10 were changed by the intervention of ulina-statin at different time. The differences of the levels of IL-6, IL-8, IL-9, and IL-10 between the ulinastatin intervention group and the control group were not significant on the day before operation, 1 day and 3 days after operation (t = -1.15 to 1.82, all P > 0.05), but the levels of IL-6, IL-8, IL-9, and IL-10 of the ulinastatin intervention group were significantly lower than those of the control group and there were statistically significant differences 5 days and 7 days after the operation (t = 3.22 and 23.51, both P<0.05) .

Conclusions: Ulinastatin has a good effect in inhibiting the inflammatory factors and can protect and repair the postoperative hepatic injury as well in patients with hepatic cystic echinococcosis.

[摘要] 目的 观察青海地区肝细粒棘球蚴病患者术后炎性因子变化, 评价乌司他丁对肝棘球蚴病患者术后炎性因子 的干预作用。方法 选取 60 例肝细粒棘球蚴病患者, 随机分为两组, 干预组术后使用乌司他丁, 对照组不使用。所有患 者于术前、术后第 1 、 3 、 5 天及第 7 天抽取外周静脉血, 应用酶联免疫吸附试验 (ELISA) 检测白细胞介素-6 (IL-6) 、IL-8 、IL-9 、IL-10 含量, 并分析乌司他丁干预的效果。结果 乌司他丁干预组术后不同时间点IL-6 、IL-8 、IL-9 和IL-10水平变化趋 势不同。乌司他丁干预组IL-6 、IL-8、IL-9 、IL-10水平与对照组在术前、术后第 1、 3天比较差异均无统计学意义 (t = −1.15 ∼ 1.82, P均> 0.05); 而在术后第 5、 7 天低于对照组, 差异均有统计学意义 (t = 3.22、 23.51, P均< 0.05)。结论 乌司他丁 在抑制肝细粒棘球蚴病患者机体炎症因子方面有很好效果, 对术后肝损伤可以起到保护和治疗作用。.

Keywords: Hepatic cystic echinococcosis; Inflammatory factor; Qinghai area; Ulinastatin.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Echinococcosis* / drug therapy
  • Echinococcosis* / surgery
  • Glycoproteins* / pharmacology
  • Glycoproteins* / therapeutic use
  • Humans
  • Interleukins / blood
  • Liver / drug effects
  • Liver / surgery
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Glycoproteins
  • Interleukins
  • urinastatin